CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1,600 target
Drug / intervention
glyceryl nitratedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00121901
NCT00121901Phase 3Completed

Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?

Hvidovre University Hospital·interventional·Posted Jul 21, 2005·Updated Oct 18, 2007

In Brief

A Phase 3 clinical trial evaluating glyceryl nitrate for Pancreatitis. Completed, enrolled 1,600 participants across 14 sites in 4 countries.

Detailed Summary

Post-ERCP pancreatitis can be a serious complication to ERCP. Two studies have shown a promising preventive effect of glyceryl nitrate. This study should provide a final answer to the clinical question: Does glyceryl nitrate prevent post-ERCP pancreatitis? The study is a prospective, randomized, double blind, placebo-controlled multicenter trial. The investigators intend to include 1600 patients from Norway, Sweden, Denmark, and France. The patients will receive either placebo or a glyceryl nitrate patch (15 mg/24 hours). Follow-up will occur after 7 days. The primary outcome measure will be post-ERCP pancreatitis, and secondary outcome measures will be mild, moderate and severe pancreatitis; post procedure pancreatitis-related mortality; and adverse events.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatitis
CountriesDenmark, France, Norway, Sweden
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 21, 2005
Enrollment StartOct 1, 2004
Study CompletionOct 1, 2007
TodayJul 2, 2026
Posted 20.9 years ago

Interventions

glyceryl nitratedrug